XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.pharmaceutical-technology.com/uncategorized/newsglaxosmithkline-to-sell-thrombosis-brands-to-aspen/20%Daily2013-09-30 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsanida-pharma-receives-parkinsons-grant-from-michael-j-fox-foundation/20%Daily2013-09-30 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsuks-cancer-drug-fund-extended-to-2016/20%Daily2013-09-29 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsboehringer-ingelheim-cancer-drug-shows-positive-results-in-phase-iii-trial/20%Daily2013-09-29 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsuk-cancer-study-group-co-fund-research-new-cancer-treatment/20%Daily2013-09-26 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsramucirumab-misses-endpoint-for-breast-cancer-proves-effective-gastric-cancer/20%Daily2013-09-26 17:30
https://www.pharmaceutical-technology.com/features/feature-treating-type-two-diabetes-century-pandemic/20%Daily2013-09-25 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsnovel-brain-cancer-drug-shows-positive-signs-in-phase-1-clinical-trial/20%Daily2013-09-25 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsbayers-hypertension-drug-granted-orphan-drug-designation-by-fda/20%Daily2013-09-25 17:30
https://www.pharmaceutical-technology.com/uncategorized/newstype-2-diabetes-linked-anti-depressant-use/20%Daily2013-09-24 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsus-fda-refuses-approve-mercks-selective-relaxant-binding-agent/20%Daily2013-09-24 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsgsk-china-sales-may-take-30-hit-due-to-bribery-scandal/20%Daily2013-09-23 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsgsk-hepatitus-c-treatment-granted-additional-indication-in-europe/20%Daily2013-09-23 17:30
https://www.pharmaceutical-technology.com/features/feature-market-insight-patent-cliff-fertile-environment-generics/20%Daily2013-09-22 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsscientists-close-to-developing-universal-flu-vaccine/20%Daily2013-09-22 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsucsd-researchers-develop-new-antibiotics-detection-technique/20%Daily2013-09-22 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsgsk-signs-deal-with-barda-for-anti-anthrax-medication/20%Daily2013-09-19 17:30
https://www.pharmaceutical-technology.com/uncategorized/newspharma-companies-release-survey-results-showing-britons-better-access-new-cancer-drugs/20%Daily2013-09-19 17:30
https://www.pharmaceutical-technology.com/features/feature-bioelectronic-medicine-body-electrical-language-gsk/20%Daily2013-09-18 17:30
https://www.pharmaceutical-technology.com/uncategorized/newseuropean-commission-gives-marketing-approval-prostate-cancer-drug/20%Daily2013-09-18 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-investigating-eye-care-unit-bribery-claims-china/20%Daily2013-09-18 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-first-generic-xeloda-colon-cancer/20%Daily2013-09-17 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsmultiple-sclerosis-treatment-endorsed-ema/20%Daily2013-09-17 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsfda-bans-use-any-drugs-made-ranbaxy-facility-mohali-india/20%Daily2013-09-16 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsgenzymes-multiple-sclerosis-treatment-approved-by-european-commission/20%Daily2013-09-16 17:30
https://www.pharmaceutical-technology.com/uncategorized/newshuman-study-discovers-vital-information-h1n1-influenza-virus/20%Daily2022-12-02 14:29
https://www.pharmaceutical-technology.com/uncategorized/newscolumbia-laboratories-acquires-uk-pharma-developer/20%Daily2013-09-15 17:30
https://www.pharmaceutical-technology.com/uncategorized/newschinese-authorities-probe-bayer-domestic-drug-companies/20%Daily2021-10-27 12:49
https://www.pharmaceutical-technology.com/uncategorized/newsgeneric-versions-high-cholesterol-drug-lovaza-developed-rules-judge/20%Daily2013-09-12 17:30
https://www.pharmaceutical-technology.com/uncategorized/newstrial-vaccine-monkey-virus-similar-hiv-success/20%Daily2013-09-11 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsroche-partners-inovio-pharma-prostate-cancer-hepatitis-b-therapies/20%Daily2013-09-11 17:30
https://www.pharmaceutical-technology.com/features/feature-dna-patent-law-what-does-it-mean-pharma/20%Daily2013-09-10 17:45
https://www.pharmaceutical-technology.com/uncategorized/newsastrazeneca-strikes-50m-licensing-deal-with-merck-for-ovarian-cancer-treatment/20%Daily2013-09-10 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsdata-supports-fast-track-approval-roches-breast-cancer-drug-say-fda/20%Daily2013-09-10 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsmelanoma-cancer-vaccine-goes-into-phase-i-clinical-testing/20%Daily2013-09-09 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsfda-approves-pancreatic-cancer-drug-abraxane/20%Daily2013-09-09 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsgsk-considers-pulling-out-china/20%Daily2013-09-08 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsbayer-seeks-ema-approval-for-marketing-of-regorafenib-to-treat-gist/20%Daily2013-09-08 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-enters-partnership-develop-stem-cell-technology-kidney-transplant-patients/20%Daily2013-09-05 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsgsk-cancer-vaccine-fails-pass-melanoma-clinical-trial/20%Daily2013-09-05 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsphase-i-trial-clinical-hiv-vaccine-announced-success/20%Daily2013-09-04 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsgroundbreaking-virus-survey-could-re-focus-pathogen-research/20%Daily2013-09-04 17:30
https://www.pharmaceutical-technology.com/uncategorized/newschinese-authorities-claim-gsk-bribery-scandal-co-ordinated-company-level/20%Daily2013-09-03 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsnew-partnership-develop-immortal-cell-lines-boost-biosimilar-production/20%Daily2013-09-03 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsema-approves-gsks-melanoma-drug-tafinlar/20%Daily2013-09-02 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsnovartis-heart-failure-drug-shows-promise/20%Daily2013-09-02 17:30
https://www.pharmaceutical-technology.com/features/feature-august-stories-novartis-drug-investigation-amgen-buys-onyx/20%Daily2013-09-01 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsuniversity-warwick-wins-award-outstanding-drug-discovery-capabilities-chagas-disease/20%Daily2013-09-01 17:30
https://www.pharmaceutical-technology.com/uncategorized/newsroches-injectable-herceptin-formula-endorsed-by-eu/20%Daily2013-09-01 17:30